In the event there is an adverse FDA event, WMGI may terminate merger agreement upon payment of $30 million fee. See Merger Agreement, Article IX, Termination, subsections 9.3 and 9.5.
The Merger Agreement is included in WMGI's Form 8-K filed 11-19-2012.